Johnson & Johnson Accepts Offer From The Carlyle Group to Acquire Ortho-Clinical Diagnostics (JNJ, CG)

Johnson & Johnson (JNJ) reported that it has accepted an offer from The Carlyle Group (CG) to purchase its Ortho-Clinical Diagnostics business for $4.15 billion.

JNJ was presented with the offer on January 16 and accepted it after the company consulted with the relevant works councils and trade unions. The deal is expected to close in the middle of 2014.

The company said that it will report any updates at its next earnings call on April 15.

Johnson & Johnson shares were up 76 cents, or 0.78%, during pre-market trading Monday. The stock is up 6.39% YTD.

The Carlyle Group shares were up 36 cents, or 1.05% during pre-market trading Monday. The stock is down 3.71% YTD.